Literature DB >> 17637809

Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids.

M Seiffert1, S Stilgenbauer, H Döhner, P Lichter.   

Abstract

Accumulation of neoplastic cells in B-cell chronic lymphocytic leukemia (B-CLL) is thought to be due to intrinsic defects in the apoptotic machinery of the leukemic cells or to an altered, survival-stimulating microenvironment in vivo. Despite their long survival in vivo, B-CLL cells undergo rapid spontaneous apoptosis ex vivo. To maintain survival in vitro, we established a coculture system using the human bone marrow-derived stromal cell line HS-5. The microenvironment in these cocultures lead to B-CLL cell survival for at least several months and therefore provided a tool for valid in vitro analysis, mimicking the in vivo situation. Although primary B lymphocytes are notoriously resistant to most gene transfer techniques, we achieved high transfection efficiency and cell viability in this coculture system by using a nucleofection-based strategy. Surprisingly, the introduction of circular plasmid DNA into B cells and B-CLL cells induced rapid apoptosis, which was independent of the type of transgene used, but dependent on the DNA concentration. However, transfection of these cells with mRNA was highly efficient and resulted in sustained cell viability and potent transgene expression. The described procedure represents a new approach to study gene function in primary B cells and B-CLL cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17637809     DOI: 10.1038/sj.leu.2404863

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  24 in total

1.  Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors.

Authors:  Lela Kardava; Susan Moir; Wei Wang; Jason Ho; Clarisa M Buckner; Jacqueline G Posada; Marie A O'Shea; Gregg Roby; Jenny Chen; Hae Won Sohn; Tae-Wook Chun; Susan K Pierce; Anthony S Fauci
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells.

Authors:  Iris Gehrke; Rajesh Kumar Gandhirajan; Simon Jonas Poll-Wolbeck; Michael Hallek; Karl-Anton Kreuzer
Journal:  Mol Med       Date:  2011-04-14       Impact factor: 6.354

3.  Astrocytic responses to DNA delivery using nucleofection.

Authors:  H Muyderman; W P Yew; B Homkajorn; N R Sims
Journal:  Neurochem Res       Date:  2010-08-21       Impact factor: 3.996

4.  On CK2 regulation of chronic lymphocytic leukemia cell viability.

Authors:  Leila R Martins; Paulo Lúcio; Milene C Silva; Paula Gameiro; Maria G Silva; João T Barata
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

5.  Boosting Intracellular Delivery of Lipid Nanoparticle-Encapsulated mRNA.

Authors:  Siddharth Patel; N Ashwanikumar; Emily Robinson; Allison DuRoss; Conroy Sun; Kerry E Murphy-Benenato; Cosmin Mihai; Örn Almarsson; Gaurav Sahay
Journal:  Nano Lett       Date:  2017-08-24       Impact factor: 11.189

6.  Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cells.

Authors:  Srinivas Mamidi; Simon Höne; Claudia Teufel; Leopold Sellner; Thorsten Zenz; Michael Kirschfink
Journal:  Oncoimmunology       Date:  2015-01-22       Impact factor: 8.110

7.  Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells.

Authors:  Maria C Palanca-Wessels; Anthony J Convertine; Richelle Cutler-Strom; Garrett C Booth; Fan Lee; Geoffrey Y Berguig; Patrick S Stayton; Oliver W Press
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

8.  Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeleton.

Authors:  P B Knudsen; B Hanna; S Ohl; L Sellner; T Zenz; H Döhner; S Stilgenbauer; T O Larsen; P Lichter; M Seiffert
Journal:  Leukemia       Date:  2013-11-27       Impact factor: 11.528

9.  IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK.

Authors:  Rossana Maffei; Stefania Fiorcari; Stefania Benatti; Claudio Giacinto Atene; Silvia Martinelli; Patrizia Zucchini; Leonardo Potenza; Mario Luppi; Roberto Marasca
Journal:  Leukemia       Date:  2021-02-23       Impact factor: 11.528

10.  Efficient inhibition of miR-155 function in vivo by peptide nucleic acids.

Authors:  Martin M Fabani; Cei Abreu-Goodger; Donna Williams; Paul A Lyons; Adrian G Torres; Kenneth G C Smith; Anton J Enright; Michael J Gait; Elena Vigorito
Journal:  Nucleic Acids Res       Date:  2010-03-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.